L’immunoterapia negli stadi precoci del tumore del polmone: quale ruolo per la terapia neoadiuvante? tinyurl.com/2om2e46q

Today our important study on air pollutants in the promotion of lung cancer has been published in nature led by Will Hill Emilia Lim Clare Weeden Swanton Lab ...Thread below🧵nature.com/articles/s4158…

Just out - academic work on marker adjusted chemotherapy! Thanks to Nikolaj Frost + colleagues! Rationale and Design of the Phase II ANTELOPE Study of Atezolizumab, C... sciencedirect.com/science/articl… #LCSM

☄️#PressRelease The combination of Osimertinib plus chemo showed a strong PFS improvement vs Osi alone for patients with EGFR-mutated advanced lung cancer in FLAURA2 Ph III trial #LCSM 📌2023 will be an historical year for EGFR+ management: stay tuned 🔊 astrazeneca.com/media-centre/p…

Congratulations to two outstanding #physicianscientists in #LungCancer David Carbone MD + Charles Swanton - both selected as OncLive.com 2023 Giants Of Cancer Care! 🫁🔬🧫🥼🧪 Their studies have advanced paradigms for #LungCancer #screening + treatment. OncoAlert #AACR23 #LCSM

#ASCO23 ASCO Abs#9006 SCARLET: Ph II study of sotorasib + carbo/pem in #NSCLC w/ , WJOG14821L ➡️ N=30, 1L ➡️ ORR 88.9% ➡️ PFS NR Need longer f/u. tinyurl.com/56xcb69f KRASKickers OncoAlert HemOnc Today

Awarness of lung cancer screening #RISP WALCE APS 🫁 check it out what you can do for yourself if you are active smoker!

Check this out ⬇️ Our publication on #genomic profiling in solid tumors‼️ Thanks to Nicola Normanno for this opportunity! 🧬🫁💊

Sapevi che le persone colpite da tumore ai polmoni potrebbero avere difficoltà finanziarie a causa della malattia? WALCE collabora a questo sondaggio di Lung Cancer Europe: ✅Rivolto a persone affette da tumore del polmone ⏰Richiede 10 minuti ✔️Anonimo surveymonkey.com/r/LuCESurvey20…

Dati di sopravvivenza globale dello studio ADAURA: vittoria schiacciante, con qualche contestazione tinyurl.com/2xvzeh8z

Queste sono le giornate che valgono la pena‼️ Siamo già nel futuro e ascoltare le parole di chi il #tumorealpolmone lo vive quotidianamente è un privilegio! A simona il merito dell’iniziativa! WALCE APS AIOM Paolo Tralongo 🧬🔬🦋🩸

Great honor to be part of this terrific faculty! Thanks to Luisella Righi and all organizers SIAPEC #MasterofThoracicPathology #lungcancer #precisionmedicine

🚴 #fundraising Quando la bici fa davvero bene... 🧡 🚴‍♀️ "Una pedalata contro il tumore del polmone. Obiettivo: raccogliere fondi per il progetto ‘Al tuo Fianco nel Percorso di Cura’ di WALCE" repubblica.it/salute/dossier… #Charity #sportchallenge #support #charityevents

Giornate di sensibilizzazione sui tumori testa-collo #makesensecampaign #aiocc #aslcn2 Mettete la testa a posto‼️

Congrats to Sandra Ortiz-Cuaran for this podcast! Emerging therapies for #BRAF mutant #NSCLC 💊 Proud to be part of #BOLEROConsortium focused on BRAF+ lung cancer patients IASLC BrafBombers

Are you ready for the future?? It is happening now! See our 4D experience with virtual reality! #ImmersiveLAB #lungcancer 👇🏻 OncoAlert Luisella Righi Roche Italia

Is stage 3 ur-NSCLC curable? 3-year OS in 1154 pts enrolled in PAC-R real-world study. 63.2% OS (67% in PD-L1 pos), 42.2% PFS. Excellent safety profile. So many thanks to all the investigators and patients. We look forward to the 5-year update! esmoopen.com/article/S2059-…

As part of our FRIDAY NEWS: VOICES of LuCE section, we would like to make you aware that June is ALK+ Cancer Awareness Month. Read more about our member organisation ALK Positive UK and the work it does here: alkpositive.org.uk #ALKPositiveAwarenessMonth #ALKPositive

Lung Cancer - A One Way Ticket cc Lucy Kalanithi academic.oup.com/jncics/article…

A great opportunity and honor to be part of this! Working to advance clinical opportunities for rare alterations in #NSCLC BrafBombers OncoAlert Thanks to all the BOLERO CONSORTIUM 🫁🦋 and Università di Torino